Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.
| Revenue (Most Recent Fiscal Year) | $12.06M |
| Net Income (Most Recent Fiscal Year) | $-14.09M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.00 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -80.42% |
| Net Margin (Trailing 12 Months) | -80.42% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -188.47% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.23 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.16 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 1.90 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-3.34 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.05 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.66 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.08 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 24.91M |
| Free Float | 22.40M |
| Market Capitalization | $13.26M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 1.22 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 10.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 3.89% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |